genedrive (LON:GDR) Trading Down 0.2% – Time to Sell?

genedrive plc (LON:GDR) shares fell 0.2% during trading on Thursday . The company traded as low as GBX 1.15 and last traded at GBX 1.22. 2,064,769 shares changed hands during trading, a decline of 69% from the average session volume of 6,604,662 shares. The stock had previously closed at GBX 1.23.

genedrive Stock Down 0.2%

The stock has a market capitalization of £19.64 million, a P/E ratio of -1.55 and a beta of -0.04. The firm’s 50-day simple moving average is GBX 1.06 and its 200 day simple moving average is GBX 1.02. The company has a debt-to-equity ratio of -120.48, a quick ratio of 5.52 and a current ratio of 0.99.

genedrive (LON:GDR) last announced its quarterly earnings results on Monday, March 30th. The company reported GBX (0.30) EPS for the quarter. genedrive had a negative net margin of 500.75% and a negative return on equity of 1,044.57%. As a group, research analysts expect that genedrive plc will post 209.9999867 EPS for the current year.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.